Company Badge
USPTO Data Jan 1 1976 - Dec 30 2025
5 Patents
#44 in Burlingame, CA
#11,738 in California
#50,234 in US
Humanigen, Inc.
Forward Citations = 4
5 inventors:
Burlingame, CA, United States of America
Humanigen, Inc.
CIPO Patents = 1
EPO Patents = 5
Trademarks = 1
Forward Citations = 4
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Cameron Durrant (4 out of 6 patents)
Dale Chappell (4 out of 5 patents)
Christopher Robert Bebbington (1 out of 44 patents)
4. Kenneth R Luehrsen (1 out of 1 patent)
5. Geoffrey T Yarranton (1 out of 28 patents)
6. Christina Yi (2 patents)
7. Andrew Mark Scott (3 patents)
8. Carmelina Murone (1 patent)
9. Catherine To (1 patent)
10. David M Martinez (27 patents)
11. Kenneth Luehrsen (0 patent)
12. Kenneth Luehrsen (0 patent)
13. Martin Lackmann (0 patent)
14. Kenneth Luehrsen (0 patent)
5 patents:
Humanigen, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies for unmet needs in oncology and infectious diseases. Their lead product candidate, lenzilumab, is being evaluated for the treatment of cytokine storm associated with COVID-19. Humanigen is committed to advancing innovative therapies to improve the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
1 patent (CIPO):
Please report any incorrect information to support@idiyas.com
5 patents (EPO):
Please report any incorrect information to support@idiyas.com